Get our newsletters

St. Luke’s Allentown Campus first in region to have AI-driven Ethos cancer treatment

Posted

St. Luke’s Allentown Campus is the first in Pennsylvania, New Jersey and Delaware to acquire the Varian Ethos therapy system, advancing treatment for cancer patients in the Lehigh Valley and surrounding areas.

On Sept. 28, the new system – located at the St. Luke’s Cancer Center, 240 Cetronia Road, Allentown – went live. Ethos therapy is an artificial intelligence (AI)-driven holistic solution designed to increase radiotherapy’s capability, flexibility and efficiency. This new solution can deliver an entire adaptive treatment in a typical 15-minute timeslot, from patient setup through treatment delivery. The goal is to target the tumor better, reduce the dose to healthy tissue and potentially improve overall outcomes.

The streamlined workflow of Ethos therapy is enabled by its AI-driven planning and contouring capabilities. The physician defines their clinical intent from predefined templates, and the initial treatment plan is generated based on the physician’s intent. The treatment plan is adapted in response to the variability of the tumor’s shape and cellular characteristics, along with fluctuations in the tumor’s position due to changes in nearby organs.

Ethos therapy offers the use of multimodality images, such as Magnetic resonance imaging (MRI), positron emission tomography (PET) and computed tomography (CT) at the console.


Join our readers whose generous donations are making it possible for you to read our news coverage. Help keep local journalism alive and our community strong. Donate today.


X